These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 24273995)
1. [The present and future prospects in rapid molecular diagnosis of tuberculosis and MDR-TB (First Part)]. Tănăsescu M; Didilescu C; Marica C Pneumologia; 2013; 62(3):134-8. PubMed ID: 24273995 [TBL] [Abstract][Full Text] [Related]
2. [Present and future perspectives for the rapid molecular diagnosis of TB and MDR-TB]. Tanasescu M; Didilescu C; Marica C Pneumologia; 2013; 62(4):198-205. PubMed ID: 24734352 [TBL] [Abstract][Full Text] [Related]
3. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance. Alcaide F; Coll P Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565 [TBL] [Abstract][Full Text] [Related]
4. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
5. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071 [TBL] [Abstract][Full Text] [Related]
6. Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis. Ahmad S; Mokaddas E J Infect Public Health; 2014; 7(2):75-91. PubMed ID: 24216518 [TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
8. Management of multidrug resistant tuberculosis. Daley CL; Caminero JA Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005 [TBL] [Abstract][Full Text] [Related]
9. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis. Rosales S; Pineda-García L; Andino N; Almendarez N; Membreño H; Hoffner SE Int J Tuberc Lung Dis; 2009 Dec; 13(12):1542-9. PubMed ID: 19919774 [TBL] [Abstract][Full Text] [Related]
11. The management of tuberculosis: epidemiology, resistance and monitoring. Bang D Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374 [TBL] [Abstract][Full Text] [Related]
12. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting. Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840 [TBL] [Abstract][Full Text] [Related]
13. [New methods of diagnosis in tuberculosis]. Slim-Saidi L; Mehiri-Zeghal E; Ghariani A; Tritar F Rev Pneumol Clin; 2015; 71(2-3):110-21. PubMed ID: 25754128 [TBL] [Abstract][Full Text] [Related]
14. Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay. Ramos E; Fissette K; de Rijk P; Palomino JC; Martin A Int J Tuberc Lung Dis; 2012 Jan; 16(1):110-3. PubMed ID: 22236855 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and detection of drug-resistant strains of M. tuberculosis. Ferraro MJ; Klietmann W; Lee JT AIDS Clin Care; 1995 Apr; 7(4):27-9, 36. PubMed ID: 11370656 [TBL] [Abstract][Full Text] [Related]
16. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Barnard M; Albert H; Coetzee G; O'Brien R; Bosman ME Am J Respir Crit Care Med; 2008 Apr; 177(7):787-92. PubMed ID: 18202343 [TBL] [Abstract][Full Text] [Related]
17. [Standardization of laboratory tests for tuberculosis and their proficiency testing]. Abe C Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226 [TBL] [Abstract][Full Text] [Related]
18. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases. Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008 [TBL] [Abstract][Full Text] [Related]
19. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Migliori GB; Besozzi G; Girardi E; Kliiman K; Lange C; Toungoussova OS; Ferrara G; Cirillo DM; Gori A; Matteelli A; Spanevello A; Codecasa LR; Raviglione MC; Eur Respir J; 2007 Oct; 30(4):623-6. PubMed ID: 17690121 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Ahmad S; Mokaddas E Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]